CHENGDU MIAOJI MEDICAL TECHNOLOGY

Chengdu Miaoji Medical Technology Co., Ltd., was founded in 2015 and is based in Chengdu, China. The company has a highly efficient investment team and has participated in the investment management of multiple leading global biomedical technology companies. With its unique insight into the healthcare industry, Chengdu Miaoji is committed to investing in and supporting firms across multiple healthcare sectors.

#SimilarOrganizations #Financial #More

CHENGDU MIAOJI MEDICAL TECHNOLOGY

Industry:
Finance Health Care

Founded:
2015-01-01

Status:
Active


Similar Organizations

allele-fund-logo

Allele Fund

Allele Fund is an investment fund that invests in high-growth healthcare and technology companies.

bluered-partners-logo

BlueRed Partners

BlueRed Partners is a venture capital fund that invests in the e-commerce, finance, healthcare, agriculture, technology, and retail sectors.

Investments List

Date Company Article Money raised
2019-02-25 Gracell Biotechnologies Chengdu Miaoji Medical Technology investment in Series B - Gracell Biotechnologies 85 M USD

More informations about "Chengdu Miaoji Medical Technology"

Chengdu Miaoji Medical Technology - Crunchbase

Chengdu Miaoji Medical Technology Co., Ltd., was founded in 2015 and is based in Chengdu, China. The company has a highly efficient investment team and has participated in the โ€ฆSee details»

Chengdu Miaoji Medical Technology - Crunchbase

Chengdu Miaoji Medical Technology has made 2 investments. Their most recent investment was on Jan 7, 2022 , when Crystal Egg Bio raised Chengdu Miaoji Medical Technology has had โ€ฆSee details»

Chengdu Miaoji Medical Technology Co Ltd - Company Profile โ€ฆ

Company profile page for Chengdu Miaoji Medical Technology Co Ltd including stock price, company news, executives, board members, and contact informationSee details»

General

Founded in 2015 and based in Chengdu, China, Chengdu Miaoji Medical Technology is a company with a highly efficient investment team that specializes in investing in and supporting โ€ฆSee details»

Gracell Biotechnologies Completes $85 Million Series B for

Feb 25, 2019 About Chengdu Miaoji. Chengdu Miaoji Medical Technology Co., Ltd., was founded in 2015 and is based in Chengdu, China. The company has a highly efficient โ€ฆSee details»

Gracell Biotechnologies Completes $85 Million Series B for โ€ฆ

Feb 25, 2019 Chengdu Miaoji Medical Technology Co., Ltd., was founded in 2015 and is based in Chengdu, China. The company has a highly efficient investment team and has participated โ€ฆSee details»

Chengdu Miaoji Medical Technology - Crunchbase

BlueRed Partners is a venture capital fund that invests in the e-commerce, finance, healthcare, agriculture, technology, and retail sectors. Chengdu Miaoji Medical Technology and BlueRed โ€ฆSee details»

PRESS RELEASE Gracell Biotechnologies Completes $85 Million โ€ฆ

About Chengdu Miaoji Chengdu Miaoji Medical Technology Co., Ltd., was founded in 2015 and is based in Chengdu, China. The company has a highly efficient investment team and has โ€ฆSee details»

Chengdu Miaoji - CB Insights

Use the CB Insights Platform to explore Chengdu Miaoji's full profile. Chengdu Miaoji Portfolio Investments, Chengdu Miaoji Funds, Chengdu Miaoji Exits Technology VendorsSee details»

Gracell Biotechnologies Completes $85 Million Series B for โ€ฆ

SUZHOU and SHANGHAI, China, Feb. 26, 2019 /PRNewswire/ โ€” Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its $85 million series B funding today. The โ€ฆSee details»

OrbiMed, Wellington backers of Chinese biotech Gracell

Oct 29, 2020 The company is leveraging its proprietary FasTCAR and TruUCAR technology platforms to advance a pipeline of autologous and allogeneic cell therapy product candidates โ€ฆSee details»

Chengdu Miaoji Medical Technology - Contacts, Employees

Chengdu Miaoji Medical Technology Invest in multiple leading global biomedical technology companies.See details»

Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for ...

Apr 23, 2019 Up to today, the company has raised nearly US$100 million combined, with Series B financing led by Temasek, joined by Lilly Asia Ventures, Kington Capital, King Star Capital โ€ฆSee details»

Chengdu Miaoji Medical Technology - Unicorn Nest

These funds often invest in the rounds preceeding the rounds of Chengdu Miaoji Medical Technology: 1 6 Dimensions Capital. Typical Co-investors. Chengdu Miaoji Medical โ€ฆSee details»

Electronic health card: a technological solution to promote the โ€ฆ

People-centred integrated care, with an emphasis on ensuring healthcare services are well coordinated around peopleโ€™s needs, 1 is regarded as a global strategy towards universal โ€ฆSee details»

Chengdu Miaoji Medical Technology - Crunchbase

Chengdu Miaoji Medical Technology Invest in multiple leading global biomedical technology companies.See details»

Gracell Bio Announces Fast, Cost-Effective CAR-T Manufacturing โ€ฆ

Apr 23, 2019 Gracell Biotechnologies, a Suzhou immune cell gene therapy company, announced a new technology, FasT CAR-T, that shortens the manufacturing time of CAR-T โ€ฆSee details»

Li Jin - Crunchbase Person Profile

Jan 7, 2022 Organization Name . Investor Name . Lead Investor . Funding Round ... obfuscated. Jobs. Edit Jobs Section. Number of Current Jobs 1. Li Jin is the Partner at Chengdu Miaoji โ€ฆSee details»

Ireland's Medtronic to further tap market with new innovation โ€ฆ

Jun 8, 2021 Ireland's Medtronic Plc, a global leader in medical technology, announced the official opening of its Chengdu Innovation Center in Southwest China's Sichuan province, โ€ฆSee details»

linkstock.net © 2022. All rights reserved